Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 0.00 | N/A |
PEG Ratio (TTM) | N/A | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 0.00 | N/A |
P/FCF Ratio (TTM) | 0.00 | N/A |
Price to 5YR AVG Earnings Ratio | -0.49 | N/A |
Price to 5YR AVG FCF Ratio | -1.30 | N/A |
Profitability (80%) |
Company | Industry |
---|---|---|
ROA (TTM) | 9.77% | N/A |
ROE (TTM) | 85.87% | N/A |
Net Profit Margin (TTM) | 15.51% | N/A |
ROIC 5YR AVG | 258.29% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -128.07% | -287.06% | -159.31% |
Revenue | -0.07% | 63.17% | 45.40% |
Net Income | -127.49% | -317.11% | -176.56% |
Cash Flow | -72.08% | 17.47% | -85.02% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.80 | N/A |
Quick Ratio (TTM) | 1.41 | N/A |
D/E Ratio (TTM) | 1.19 | N/A |
Interest Coverage (TTM) | -10.53 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -5.48 | N/A |
Shares Outstanding Growth 5YR AVG | 6.07% | N/A |